Connection
Daniel Sherbenou to Antibodies, Bispecific
This is a "connection" page, showing publications Daniel Sherbenou has written about Antibodies, Bispecific.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.343 |
|
|
|
-
Chen X, Wong OK, Reiman L, Sherbenou DW, Post L. CD38 x ICAM-1 Bispecific Antibody Is a Novel Approach for Treating Multiple Myeloma and Lymphoma. Mol Cancer Ther. 2024 Feb 01; 23(2):127-138.
Score: 0.207
-
Lee NK, Zhang Y, Su Y, Bidlingmaier S, Sherbenou DW, Ha KD, Liu B. Cell-type specific potent Wnt signaling blockade by bispecific antibody. Sci Rep. 2018 01 15; 8(1):766.
Score: 0.136